Moreover, this may be a fully controlled response providing, for instance, in the counteraction of tumor-induced cachexia, the inhibition of catabolic pathways (IL-6, TNF-alpha) balanced with the stimulation of anabolic pathways (FoxO3a, p-AKT, p-mTOR, and P-GSK-3β) [6]. The gene discussed is AKT1; the disease is Cachexia.